Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing patients across geographies and bridging the gap of unmet needs of medical fraternity through continuous innovation. Our basic business philosophy, by its very nature, serves a social responsibility hence we have a far better reason than profits alone to drive our performance.
Delhi high court gave temporary relief to Pfizer, Abbott and Macelods over health ministry's ban on certain fixed dose combinations (FDCs). The permit is provided till 21st march from governments ban on these companies products.